This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ropinirole hydrochloride extended-release 2 mg tablets. The $1,668.36 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense that provides logistics, contracting, and military supply chain management services. The contract has an ultimate completion date of December 17, 2024, and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award did not have a set-aside designation, indicating open competition.
Generated 3/17/25, 10:01 AM